EE9900601A - Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid - Google Patents

Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid

Info

Publication number: EE9900601A
Authority: EE; Estonia
Prior art keywords: tocopherol; inhaled; powders stabilized; proliposome powders; proliposome
Prior art date: 1997-06-27

Application number

EEP199900601A

Other languages

English (en)

Estonian (et)

Inventor

Bystr�m Katarina

Nilsson Per-Gunnar

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-27

Filing date

1998-06-08

Publication date

2000-08-15

1998-06-08 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

2000-08-15 Publication of EE9900601A publication Critical patent/EE9900601A/xx

Links

GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title 1
239000000843 powder Substances 0.000 title 1
229960001295 tocopherol Drugs 0.000 title 1
229930003799 tocopherol Natural products 0.000 title 1
235000010384 tocopherol Nutrition 0.000 title 1
239000011732 tocopherol Substances 0.000 title 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EEP199900601A 1997-06-27 1998-06-08 Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid EE9900601A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88441997A	1997-06-27	1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en)	1997-06-27	1998-06-08	Proliposome powders for inhalation stabilised by tocopherol

Publications (1)

Publication Number	Publication Date
EE9900601A true EE9900601A (et)	2000-08-15

Family

ID=25384589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900601A EE9900601A (et)	1997-06-27	1998-06-08	Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid

Country Status (18)

Country	Link
EP (1)	EP1001749A1 (id)
JP (1)	JP2002510311A (id)
KR (1)	KR20010014163A (id)
CN (1)	CN1260713A (id)
AU (1)	AU729100B2 (id)
BR (1)	BR9810280A (id)
CA (1)	CA2295028A1 (id)
EE (1)	EE9900601A (id)
HU (1)	HUP0003207A3 (id)
ID (1)	ID23192A (id)
IL (1)	IL133478A0 (id)
IS (1)	IS5304A (id)
NO (1)	NO996439L (id)
NZ (1)	NZ501672A (id)
PL (1)	PL337723A1 (id)
SK (1)	SK184899A3 (id)
TR (1)	TR199903271T2 (id)
WO (1)	WO1999000111A1 (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (de) *	2000-03-28	2001-10-04	Primacare S.A.	Pro-liposomen
EP1138310A1 (de) *	2000-03-28	2001-10-04	Primacare S.A.	Pro-liposomen
EP1138313A1 (de) *	2000-03-28	2001-10-04	Primacare S.A.	Pro-liposomen
PL1888033T3 (pl) *	2005-06-09	2014-09-30	Meda Ab	Sposób i kompozycja do leczenia chorób zapalnych
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
JP6458322B2 (ja) *	2013-05-06	2019-01-30	ディーエスエムアイピーアセッツビー．ブイ．ＤｓｍＩｐＡｓｓｅｔｓＢ．Ｖ．	粉末状ビタミンｅ製剤
WO2016033549A2 (en)	2014-08-28	2016-03-03	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en)	2015-06-15	2016-12-15	Lipocine Inc.	Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) *	2015-09-29	2018-06-22	中山大学	α-生育酚在制备治疗血吸虫病药物中的应用
US11559530B2 (en)	2016-11-28	2023-01-24	Lipocine Inc.	Oral testosterone undecanoate therapy
WO2020018974A1 (en)	2018-07-20	2020-01-23	Lipocine Inc.	Liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2081474A1 (en) *	1990-05-08	1991-11-09	Manzer Durrani	Direct spray-dried drug/lipid powder composition
AR002009A1 (es) *	1994-12-22	1998-01-07	Astra Ab	Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

1998
- 1998-06-08 AU AU79456/98A patent/AU729100B2/en not_active Ceased
- 1998-06-08 EE EEP199900601A patent/EE9900601A/xx unknown
- 1998-06-08 BR BR9810280-0A patent/BR9810280A/pt not_active IP Right Cessation
- 1998-06-08 EP EP98929963A patent/EP1001749A1/en not_active Withdrawn
- 1998-06-08 CA CA002295028A patent/CA2295028A1/en not_active Abandoned
- 1998-06-08 ID IDW991656A patent/ID23192A/id unknown
- 1998-06-08 CN CN98806377A patent/CN1260713A/zh active Pending
- 1998-06-08 IL IL13347898A patent/IL133478A0/xx unknown
- 1998-06-08 KR KR1019997012234A patent/KR20010014163A/ko not_active Withdrawn
- 1998-06-08 HU HU0003207A patent/HUP0003207A3/hu unknown
- 1998-06-08 NZ NZ501672A patent/NZ501672A/en unknown
- 1998-06-08 SK SK1848-99A patent/SK184899A3/sk unknown
- 1998-06-08 TR TR1999/03271T patent/TR199903271T2/xx unknown
- 1998-06-08 WO PCT/SE1998/001090 patent/WO1999000111A1/en not_active Ceased
- 1998-06-08 JP JP50548099A patent/JP2002510311A/ja active Pending
- 1998-06-08 PL PL98337723A patent/PL337723A1/xx unknown
1999
- 1999-12-15 IS IS5304A patent/IS5304A/is unknown
- 1999-12-23 NO NO996439A patent/NO996439L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK184899A3 (en)	2000-05-16
KR20010014163A (ko)	2001-02-26
CN1260713A (zh)	2000-07-19
CA2295028A1 (en)	1999-01-07
EP1001749A1 (en)	2000-05-24
NZ501672A (en)	2001-06-29
AU7945698A (en)	1999-01-19
TR199903271T2 (en)	2000-08-21
NO996439D0 (no)	1999-12-23
BR9810280A (pt)	2000-09-12
PL337723A1 (en)	2000-08-28
IL133478A0 (en)	2001-04-30
JP2002510311A (ja)	2002-04-02
AU729100B2 (en)	2001-01-25
HUP0003207A2 (hu)	2001-02-28
NO996439L (no)	2000-02-28
IS5304A (is)	1999-12-15
ID23192A (id)	2000-03-23
WO1999000111A1 (en)	1999-01-07
HUP0003207A3 (en)	2001-03-28

Publication	Publication Date	Title
NO972847L (no)	1997-06-19	Proliposompulvere for inhalering
EE04420B1 (et)	2005-02-15	Pulberinhalaator
NO990272D0 (no)	1999-01-21	Pulver-inhalator
DE69708327D1 (de)	2001-12-20	Pulverinhalator
FI942196L (fi)	1995-11-12	Jauheinhalaattori
ID24472A (id)	2000-07-20	Pembuatan aglomerat bubuk
FI962520A7 (fi)	1996-06-17	Jauheinhalaattori
PL340284A1 (en)	2001-01-29	Modified polypeptides dependent on vitamin k
IS5487A (is)	2000-05-11	Innúðatæki
ID18427A (id)	1998-04-09	Pengkabut serbuk
AU135120S (en)	1998-09-21	Inhaler
DE69838271D1 (de)	2007-10-04	Verbesserte Atemschutzmaske
EE9900601A (et)	2000-08-15	Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid
FI964595A7 (fi)	1996-11-15	Pulveri-inhalaattori
FR2763507B1 (fr)	1999-07-02	Inhalateur
FI955441L (fi)	1997-05-11	Jauheinhalaattori
DE69824327D1 (de)	2004-07-15	Inhalationsgerät
NO20003182L (no)	2000-08-21	FremgangsmÕte for inhalering av pulverstoffer
ID19844A (id)	1998-08-06	Komponen tumbukan
SE9703829D0 (sv)	1997-10-21	Powder inhaleri
DE59807895D1 (de)	2003-05-15	Pulverklarlack
FI964489A7 (fi)	1996-11-08	Jauheinhalaattori
IT243365Y1 (it)	2002-03-04	Inalatore migliorato
SE9700945D0 (sv)	1997-03-14	Powder inhaler VII
SE9603353D0 (sv)	1996-09-16	Powder inhaler III